切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2021, Vol. 15 ›› Issue (04) : 242 -246. doi: 10.3877/cma.j.issn.1674-0807.2021.04.010

所属专题: 文献

综述

生物电阻抗在乳腺癌术后上肢淋巴水肿诊断中的应用
刘思尧1, 刘淼1, 王殊1,()   
  1. 1. 100044 北京大学人民医院乳腺中心
  • 收稿日期:2019-02-22 出版日期:2021-09-08
  • 通信作者: 王殊

Bioimpedance in the diagnosis of upper limb lymphedema after breast cancer surgery

Siyao Liu1, Miao Liu1, Shu Wang1()   

  • Received:2019-02-22 Published:2021-09-08
  • Corresponding author: Shu Wang
引用本文:

刘思尧, 刘淼, 王殊. 生物电阻抗在乳腺癌术后上肢淋巴水肿诊断中的应用[J/OL]. 中华乳腺病杂志(电子版), 2021, 15(04): 242-246.

Siyao Liu, Miao Liu, Shu Wang. Bioimpedance in the diagnosis of upper limb lymphedema after breast cancer surgery[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2021, 15(04): 242-246.

乳腺癌治疗的进步使得患者对术后生活质量有了更高的要求,而术后上肢淋巴水肿对患者的危害日益突出,寻找有效的早期筛查淋巴水肿的工具至关重要。笔者通过回顾既往有关生物电阻抗在乳腺癌术后上肢淋巴水肿诊断方面的研究,发现生物电阻抗能准确诊断已经存在的乳腺癌术后上肢淋巴水肿,相比于臂围测量、肢体体积测量、远红外测量和主观症状评分等方法,它对于亚临床阶段的淋巴水肿有更好的诊断价值。

表1 生物电阻抗对比臂围测量法诊断淋巴水肿的研究
表2 生物电阻抗对比排水法诊断淋巴水肿的研究
表3 生物电阻抗对比Perometer法诊断淋巴水肿的研究
表4 生物电阻抗对比多种淋巴水肿检测方法的研究
[1]
Vignes S, Fau-Prudhomot P, Simon L, et al. Impact of breast cancer-related lymphedema on working women [J]. Suppor Care Cancer, 2019, 28(1): 79-85.
[2]
Giray E, Akyuz G. Assessment of family caregiver burden and its relationships between quality of life, arm disability, grip strength, and lymphedema symptoms in women with postmastectomy lymphedema: a prospective cross-sectional study [J]. Eur J Breast Health, 2019, 15(2): 111-118.
[3]
Levenhagen K, Davies C, Perdomo M, et al. Diagnosis of upper quadrant lymphedema secondary to cancer: clinical practice guideline from the Oncology Section of the American Physical Therapy Association [J]. Phys Ther, 2017, 97(7): 729-745.
[4]
Ammitzboll G, Johansen C, Lanng C, et al. Progressive resistance training to prevent arm lymphedema in the first year after breast cancer surgery: Results of a randomized controlled trial [J]. Cancer, 2019, 125(10): 1683-1692.
[5]
Tandra P, Kallam A, Krishnamurthy J. Identification and management of lymphedema in patients with breast cancer [J]. J Oncol Pract, 2019, 15(5): 255-262.
[6]
Shi S, Lu Q, Fu MR, et al. Psychometric properties of the breast cancer and lymphedema symptom experience index: the Chinese version [J]. Eur J Oncol Nurs, 2016, 20: 10-16.
[7]
Fu MR, Axelrod D, Cleland CM, et al. Symptom report in detecting breast cancer-related lymphedema [J]. Breast Cancer (Dove Med Press), 2015, 7: 345-352.
[8]
Yamamoto T, Yamamoto N, Doi K, et al. Indocyanine green-enhanced lymphography for upper extremity lymphedema: a novel severity staging system using dermal backflow patterns[J]. Plast Reconstr Surg, 2011, 128(4): 941-947.
[9]
Shah C, Vicini FA, Arthur D. Bioimpedance spectroscopy for breast cancer related lymphedema assessment: clinical practice guidelines [J]. Breast J, 2016, 22(6): 645-650.
[10]
Shah C, Arthur DW, Wazer D, et al. The impact of early detection and intervention of breast cancer-related lymphedema: a systematic review [J]. Cancer Med, 2016, 5(6): 1154-1162.
[11]
Seward C, Skolny M, Brunelle C, et al. A comprehensive review of bioimpedance spectroscopy as a diagnostic tool for the detection and measurement of breast cancer-related lymphedema [J]. J Surg Oncol, 2016, 114(5): 537-542.
[12]
Engin O, Akalin E, Saribay E, et al. Easy volumeter in detection of breast cancer-related lymphedema: a validity study [J]. Lymphat Res Biol, 2019, 17(5): 543-549.
[13]
Soran A, Ozmen T, McGuire KP, et al. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study [J]. Lymphat Res Biol, 2014, 12(4): 289-294.
[14]
Hayes S, Cornish B, Newman B. Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up [J]. Breast Cancer Res Treat, 2005, 89(3): 221-226.
[15]
Hayes S, Di Sipio T, Rye S, et al. Prevalence and prognostic significance of secondary lymphedema following breast cancer [J]. Lymphat Res Biol, 2011, 9(3): 135-141.
[16]
Cornish BH, Thomas BJ, Ward LC, et al. A new technique for the quantification of peripheral oedema; with application in both unilateral and bilateral cases [J]. Angiology, 2002, 53(1): 41-47.
[17]
徐舒曼,陈莉. 乳腺癌相关淋巴水肿的治疗进展 [J/CD]. 中华乳腺病杂志(电子版), 2017, 11(4): 247-251.
[18]
Sun F, Skolny MN, Swaroop MN, et al. The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema [J]. Breast Cancer Res Treat, 2016, 157(2): 229-240.
[19]
Sun F, Hall A, Tighe MP, et al. Perometry versus simulated circumferential tape measurement for the detection of breast cancer-related lymphedema [J]. Breast Cancer Res Treat, 2018, 172(1): 83-91.
[20]
Asdourian MS, Skolny MN, Brunelle C, et al. Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis [J]. Lancet Oncol, 2016, 17(9): e392-405.
[21]
Penha TR, Botter B, Heuts EM, et al. Quality of life in patients with breast cancer-related lymphedema and reconstructive breast surgery [J]. J Reconstr Microsurg, 2016, 32(6): 484-490.
[22]
Kim P, Lee JK, Lim OK, et al. Quantitative lymphoscintigraphy to predict the possibility of lymphedema development after breast cancer surgery: retrospective clinical study [J]. Ann Rehabil Med, 2017, 41(6): 1065-1075.
[23]
Cheng MH, Pappalardo M, Lin C, et al. Validity of the novel Taiwan lymphoscintigraphy staging and correlation of Cheng lymphedema grading for unilateral extremity lymphedema [J]. Ann Surg, 2018, 268(3): 513-525.
[24]
Akita S, Nakamura R, Yamamoto N, et al. Early detection of lymphatic disorder and treatment for lymphedema following breast cancer [J]. Plast Reconstr Surg, 2016, 138(2): 192e-202e.
[25]
Czerniec SA, Ward LC, Refshauge KM, et al. Assessment of breast cancer-related arm lymphedema--comparison of physical measurement methods and self-report [J]. Cancer Invest, 2010, 28(1): 54-62.
[26]
沈莉,谢娜,王鹤玮,等. 生物电阻抗早期监测乳腺癌术后上肢淋巴水肿的敏感性与特异性研究 [J]. 中国康复医学杂志2018, 33(04): 405-408.
[27]
Ward LC, Bunce IH, Cornish BH, et al. Multi-frequency bioelectrical impedance augments the diagnosis and management of lymphoedema in post-mastectomy patients [J]. Eur J Clin Invest, 1992, 22(11): 751-754.
[28]
Cornish BH, Chapman M, Hirst C, et al. Early diagnosis of lymphedema using multiple frequency bioimpedance [J]. Lymphology, 2001, 34(1): 2-11.
[29]
Dylke ES, Ward LC. Three decades of bioelectrical Impedance spectroscopy in lymphedema assessment: an historical perspective[J]. Lymphat Res Biol202119(3):206-214.
[30]
Fu MR, Cleland CM, Guth AA, et al. L-dex ratio in detecting breast cancer-related lymphedema: reliability, sensitivity, and specificity [J]. Lymphology, 2013, 46(2): 85-96.
[31]
Box RC, Reul-Hirche HM, Bullock-Saxton JE, et al. Physiotherapy after breast cancer surgery: results of a randomised controlled study to minimise lymphoedema [J]. Breast Cancer Res Treat, 2002, 75(1): 51-64.
[32]
Smoot BJ, Wong JF, Dodd MJ. Comparison of diagnostic accuracy of clinical measures of breast cancer-related lymphedema: area under the curve [J]. Arch Phys Med Rehabil, 2011, 92(4): 603-610.
[33]
Soran A, Menekse E, Girgis M, et al. Breast cancer-related lymphedema after axillary lymph node dissection: does early postoperative prediction model work? [J]. Support Care Cancer, 201624(3):1413-1419.
[34]
Barrio AV, Eaton A, Frazier TG. A prospective validation study of bioimpedance with volume displacement in early-stage breast cancer patients at risk for lymphedema [J]. Ann Surg Oncol, 2015, 22 Suppl 3: S370-375.
[35]
Ward LC, Czerniec S, Kilbreath SL. Operational equivalence of bioimpedance indices and perometry for the assessment of unilateral arm lymphedema [J]. Lymphat Res Biol, 2009, 7(2): 81-85.
[36]
Ward LC, Czerniec S, Kilbreath SL. Quantitative bioimpedance spectroscopy for the assessment of lymphoedema [J]. Breast Cancer Res Treat, 2009, 117(3): 541-547.
[37]
Czerniec SA, Ward LC, Lee MJ, et al. Segmental measurement of breast cancer-related arm lymphoedema using perometry and bioimpedance spectroscopy [J]. Support Care Cancer, 2010, 19(5): 703-710.
[38]
Bundred NJ, Stockton C, Keeley V, et al. Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancer [J]. Breast Cancer Res Treat, 2015, 151(1): 121-129.
[39]
Qin ES, Bowen MJ, Chen WF. Diagnostic accuracy of bioimpedance spectroscopy in patients with lymphedema: A retrospective cohort analysis [J]. J Plast Reconstr Aesthet Surg, 2018, 71(7): 1041-1050.
[40]
Executive C. The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the International Society of Lymphology [J]. Lymphology, 2016, 49(4): 170-184.
[41]
McLaughlin SA, Staley AC, Vicini F, et al. Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema: recommendations from a multidisciplinary expert ASBrS panel: Part 1: definitions, assessments, education, and future directions [J]. Ann Surg Oncol, 2017, 24(10): 2818-2826.
[42]
Koelmeyer LA, Borotkanics RJ, Alcorso J, et al. Early surveillance is associated with less incidence and severity of breast cancer-related lymphedema compared with a traditional referral model of care [J]. Cancer, 2019, 125(6): 854-862.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[3] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[4] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[5] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[6] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[7] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[8] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[9] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[10] 葛睿, 陈飞, 李杰, 李娟娟, 陈涵. 多基因检测在早期乳腺癌辅助治疗中的应用价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 257-263.
[11] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[12] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[13] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[14] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[15] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
阅读次数
全文


摘要